메뉴 건너뛰기




Volumn 8, Issue 3, 2001, Pages 227-233

Treatment of metastatic breast cancer with somatostatin analogues - A meta-analysis

Author keywords

Breast cancer; Lanreotide; Meta analysis; Octreotide; Outcomes; Somatostatin; Somatuline; Treatment

Indexed keywords

ANGIOPEPTIN; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

EID: 0035069931     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.3.227     Document Type: Article
Times cited : (30)

References (37)
  • 3
    • 84942475903 scopus 로고
    • The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care
    • (1995) JAMA , vol.274 , pp. 1935-1938
    • Bero, L.1    Rennie, D.2
  • 16
    • 0031964609 scopus 로고    scopus 로고
    • Feasibility, endocrine and anti-tumor effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in postmenopausal metastatic breast cancer: A randomized study with long-term follow-up
    • (1998) Br J Cancer , vol.77 , pp. 115-122
    • Bontenbal, M.1    Foekens, J.A.2    Lamberts, S.W.3
  • 29
    • 0030994858 scopus 로고    scopus 로고
    • Somatostatin receptor subtypes sst1, sst2, sst3, sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: Comparison of mRNA analysis with receptor autoradiography
    • (1997) Int J Cancer , vol.70 , pp. 530-537
    • Schaer, J.C.1    Waser, B.2    Mengod, G.3    Reubi, J.C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.